In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis

Journal of Medical Microbiology

Volumn 48, Issue 12, 1999, Pages 1087-1093

  Dannaoui, E ^a   Borel, E ^a   Persat, F ^a   Monier, M F ^a   Piens, M A ^a   Perraud, M ^a   Chapuis, F ^b   Grillot, R ^c   Lebeau, B ^c   Burnod, J ^c   Nolard, N ^d   Symoens, F ^d   Goens, K ^d   Heinemann, S ^d   Bastide, J M ^e   Mallie M ^e   Castel, D ^e   Berthou, S ^e   Renaud, F ^e   De Mecus, T ^e   Viviani, M A ^f   Tortorano, A M ^f   Roverselli, A ^f   Cogliati, M ^f   Evans, G E ^g   Barton, R ^g   Ashbee, R ^g   Hopwood, V ^g   Meis, F ^h   Voss, A ^h   Verweij, P E ^h   Donnelly, J P ^h   Villard, J ^a   Carlotti, A ^a   Chaib, F ^a   Couble, A ^a   Casoli, A ^a   more..

^a UNIVERSITÉ LYON 1   (France)

^b Information Médicale   (France)

^c UNIV GRENOBLE ALPES   (France)

^d SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^e UNIV MONTPELLIER   (France)

^f Inst de Igiene e Med Preventiva   (Italy)

^g UNIVERSITY OF LEEDS   (United Kingdom)

^h RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; ITRACONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032762360     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-12-1087     Document Type: Article

References (15)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803.
2. Richardson MD, Kokki MH. Antifungal therapy in 'bone marrow failure'. Br J Haematol 1998; 100: 619-628.
3. Chryssanthou E. In vitro susceptibility of respiratory isolates of Aspergillus species to itraconazole and amphotericin B. Acquired resistance to itraconazole. Scand J Infect Dis 1997; 29: 509-512.
4. Denning DW, Venkateswarlu K, Oakley KL et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997; 41: 1364-1368.
5. Ghannoum MA, Rex JH, Galgiani JN. Susceptibility testing of fungi: Current status of correlation of in vitro data with clinical outcome. J Clin Microbiol 1996; 34: 489-495.
6. Valentin A, Le Guennec R, Rodriguez E, Reynes J, Mallie M, Bastide J-M. Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model. Antimicrob Agents Chemother 1996; 40: 1342-1345.
7. Odds FC, Van Gerven F, Espinel-Ingroff A et al. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob Agents Chemother 1998; 42: 282-288.
8. Denning DW, Radford SA, Oakley KL, Hall L, Johnson EM, Warnock DW. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother 1997; 40: 401-414.
9. Espinel-Ingroff A, Dawson K, Pfaller M et al. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrob Agents Chemother 1995; 39: 314-319.
10. Espinel-Ingroff A, Bartlett M, Bowden R et al. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol 1997; 35: 139-143.
11. NCCLS. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. M-27A. Villanova, PA, National Committee for Clinical Laboratory Standards. 1995.
12. Johnson EM, Warnock DW. Azole drug resistance in yeasts. J Antimicrob Chemother 1995; 36: 751-755.
13. Denning DW, Hanson LH, Perlman AM, Stevens DA. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis 1992; 15: 21-34.
14. Eisenstein DJ, Biddinger PW, Rhodes JC. Experimental murine invasive pulmonary aspergillosis. Am J Clin Pathol 1990; 93: 510-515.
15. Denning DW, Hall L, Jackson M, Hollis S. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Antimicrob Agents Chemother 1995; 39: 1809-1814.